A recent study evaluated a multiepitope mRNA‐liposomal nanoparticles targeting viral protease cleavage sites, which are conserved between HIV subtypes, has shown great promise by promoting CD8+ T cell activity and memory with minimal CD4+ T cell involvement and inflammation, leading to the possibility of abortion of early infection.125. Here, CD8A is linked to infection.